|
Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial |
|
|
|
Titel: |
Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial |
Auteur: |
Gholinataj jelodar, Mohsen Rafieian, Shahab Saghafi, Fatemeh Hadad zedegan, Navid Birjandi, Behnaz Rafieian, Shiva Allah dini, Azadeh Dehghanpour, Hanieh Khalaj, Fatemeh Zare, Samira Dehghan Chenari, Hanieh Hajimaghsoudi, Majid Mojtaba Sohrevardi, Seyed Mirzaei, Samaneh Jamialahmadi, Tannaz Atkin, Stephen L. Sahebkar, Amirhossein |
Verschenen in: |
International immunopharmacology |
Paginering: |
Jaargang 115 () nr. C pagina's p. |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|